Cargando…

Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels

Two-pore domain potassium (K2P) channels are a diverse family of potassium channels. K2P channels generate background leak potassium currents to regulate cellular excitability and are thereby involved in a wide range of neurological disorders. K2P channels are modulated by a variety of physicochemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Lu, Xu, Guangyin, Jiang, Ruotian, Luo, Yuncheng, Zuo, Yunxia, Liu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199554/
https://www.ncbi.nlm.nih.gov/pubmed/33827408
http://dx.doi.org/10.2174/1570159X19666210407152528
_version_ 1784727864429510656
author Huang, Lu
Xu, Guangyin
Jiang, Ruotian
Luo, Yuncheng
Zuo, Yunxia
Liu, Jin
author_facet Huang, Lu
Xu, Guangyin
Jiang, Ruotian
Luo, Yuncheng
Zuo, Yunxia
Liu, Jin
author_sort Huang, Lu
collection PubMed
description Two-pore domain potassium (K2P) channels are a diverse family of potassium channels. K2P channels generate background leak potassium currents to regulate cellular excitability and are thereby involved in a wide range of neurological disorders. K2P channels are modulated by a variety of physicochemical factors, such as mechanical stretch, temperature, and pH. In the peripheral nervous system, K2P channels are widely expressed in nociceptive neurons and play a critical role in pain perception. In this review, we summarize the recent advances in the pharmacological properties of K2P channels, with a focus on the exogenous small-molecule activators targeting K2P channels. We emphasize the subtype-selectivity, cellular and in vivo pharmacological properties of all the reported small-molecule activators. The key underlying analgesic mechanisms mediated by K2P are also summarized based on the data in the literature from studies using small-molecule activators and genetic knock-out animals. We discuss the advantages and limitations of the translational perspectives of K2P in pain medicine and provide outstanding questions for future studies in the end.
format Online
Article
Text
id pubmed-9199554
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-91995542022-07-10 Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels Huang, Lu Xu, Guangyin Jiang, Ruotian Luo, Yuncheng Zuo, Yunxia Liu, Jin Curr Neuropharmacol Neurology Two-pore domain potassium (K2P) channels are a diverse family of potassium channels. K2P channels generate background leak potassium currents to regulate cellular excitability and are thereby involved in a wide range of neurological disorders. K2P channels are modulated by a variety of physicochemical factors, such as mechanical stretch, temperature, and pH. In the peripheral nervous system, K2P channels are widely expressed in nociceptive neurons and play a critical role in pain perception. In this review, we summarize the recent advances in the pharmacological properties of K2P channels, with a focus on the exogenous small-molecule activators targeting K2P channels. We emphasize the subtype-selectivity, cellular and in vivo pharmacological properties of all the reported small-molecule activators. The key underlying analgesic mechanisms mediated by K2P are also summarized based on the data in the literature from studies using small-molecule activators and genetic knock-out animals. We discuss the advantages and limitations of the translational perspectives of K2P in pain medicine and provide outstanding questions for future studies in the end. Bentham Science Publishers 2022-01-10 2022-01-10 /pmc/articles/PMC9199554/ /pubmed/33827408 http://dx.doi.org/10.2174/1570159X19666210407152528 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Neurology
Huang, Lu
Xu, Guangyin
Jiang, Ruotian
Luo, Yuncheng
Zuo, Yunxia
Liu, Jin
Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title_full Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title_fullStr Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title_full_unstemmed Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title_short Development of Non-opioid Analgesics Targeting Two-pore Domain Potassium Channels
title_sort development of non-opioid analgesics targeting two-pore domain potassium channels
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199554/
https://www.ncbi.nlm.nih.gov/pubmed/33827408
http://dx.doi.org/10.2174/1570159X19666210407152528
work_keys_str_mv AT huanglu developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels
AT xuguangyin developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels
AT jiangruotian developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels
AT luoyuncheng developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels
AT zuoyunxia developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels
AT liujin developmentofnonopioidanalgesicstargetingtwoporedomainpotassiumchannels